99-21264. Disease, Disability and Injury Prevention and Control Special Emphasis Panel: Strategies to Prevent Genital Herpes Simplex Infections: Building a National Prevention Program  

  • [Federal Register Volume 64, Number 158 (Tuesday, August 17, 1999)]
    [Notices]
    [Pages 44738-44739]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-21264]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Disease, Disability and Injury Prevention and Control Special 
    Emphasis Panel: Strategies to Prevent Genital Herpes Simplex 
    Infections: Building a National Prevention Program
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following meeting.
    
        Name: Disease, Disability and Injury Prevention and Control 
    Special Emphasis Panel: Strategies to Prevent Genital Herpes Simplex 
    Infections: Building a National Prevention Program, Program 
    Announcement #99115.
        Times and Dates: 8:30 a.m.-9:00 a.m., August 17, 1999 (Open); 
    9:00 a.m.-4:30 p.m., August 17, 1999 (Closed); 8:30 a.m.-Noon, 
    August 18, 1999 (Closed)
    
    [[Page 44739]]
    
        Place: CDC, National Center for HIV, STD and TB Prevention, 
    Corporate Square, Building 12, Conference Room 3106, Atlanta, GA 
    30329.
        Status: Portions of the meeting will be closed to the public in 
    accordance with provisions set forth in section 552b(c)(4) and (6), 
    Title 5 U.S.C., and the Determination of the Associate Director for 
    Management and Operations, CDC, pursuant to Public Law 92-463.
        Matters to be Discussed: The meeting will include the review, 
    discussion, and evaluation of applications received in response to 
    Program Announcement #99115. Due to administrative delays, this 
    notice is published less than 15 days prior to the meeting.
        Contact Person For More Information: Beth Wolfe, Prevention 
    Support Office, National Center for HIV, STD, and TB Prevention, 
    CDC, Corporate Square Office Park, 11 Corporate Square Boulevard, M/
    S E07, Atlanta, Georgia 30329, telephone 404/639-8025, e-mail 
    EOW1@cdc.gov.
        The Director, Management Analysis and Services Office, has been 
    delegated the authority to sign Federal Register Notices pertaining 
    to announcements of meetings and other committee management 
    activities, for both the Centers for Disease Control and Prevention 
    and the Agency for Toxic Substances and Disease Registry.
    
        Dated: August 9, 1999.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 99-21264 Filed 8-12-99; 1:42 pm]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
08/17/1999
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
99-21264
Dates:
8:30 a.m.-9:00 a.m., August 17, 1999 (Open); 9:00 a.m.-4:30 p.m., August 17, 1999 (Closed); 8:30 a.m.-Noon, August 18, 1999 (Closed)
Pages:
44738-44739 (2 pages)
PDF File:
99-21264.pdf